Literature DB >> 11163416

Neurological sequelae and long-term behavioural assessment of rats with transient middle cerebral artery occlusion.

M Modo1, R P Stroemer, E Tang, T Veizovic, P Sowniski, H Hodges.   

Abstract

Animal models of stroke, notably transient middle cerebral artery occlusion (MCAo), are used to assess the efficacy of pharmacological and transplant treatments. Long-term studies (>1 month) of the functional effects of treatments in animal models are required to predict treatments likely to improve dysfunctions associated with stroke damage. These pre-clinical studies require (1) optimum post-operative care to ensure long-term survival, (2) methods for assignment of rats to groups with equivalent impairments to reduce variability and enhance detection of treatment effects, and (3) behavioural tests that detect long-term stable deficits. For long-term functional assessment, a battery of behavioural tests sensitive to a range of deficits observed after MCAo was developed. The bilateral asymmetry test evaluated the time course of sensory neglect. Deficits of motor integration were examined in the footfault test, and motor bias was assessed by pharmacological stimulation of rotation. The water maze was used to detect long-term deficits in spatial information processing. Long-term differences between control and MCAo animals in this battery of tests indicate that the protocol provides an efficient assessment suitable for evaluating treatment outcomes in pre-clinical studies of stroke, and that the post-operative care procedure and method of assignment to groups were effective.

Entities:  

Mesh:

Year:  2000        PMID: 11163416     DOI: 10.1016/s0165-0270(00)00329-0

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  58 in total

1.  Functional assessments in the rodent stroke model.

Authors:  Krystal L Schaar; Miranda M Brenneman; Sean I Savitz
Journal:  Exp Transl Stroke Med       Date:  2010-07-19

2.  A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke.

Authors:  M Modo; J S Beech; T J Meade; S C R Williams; J Price
Journal:  Neuroimage       Date:  2008-06-25       Impact factor: 6.556

3.  Attachment of stem cells to scaffold particles for intra-cerebral transplantation.

Authors:  Ellen Bible; David Y S Chau; Morgan R Alexander; Jack Price; Kevin M Shakesheff; Michel Modo
Journal:  Nat Protoc       Date:  2009-09-17       Impact factor: 13.491

Review 4.  Experimental approaches to study functional recovery following cerebral ischemia.

Authors:  Anu Lipsanen; Jukka Jolkkonen
Journal:  Cell Mol Life Sci       Date:  2011-05-29       Impact factor: 9.261

5.  Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations.

Authors:  Michel Modo
Journal:  J Exp Stroke Transl Med       Date:  2009-01

6.  A Critical Re-Examination of the Intraluminal Filament MCAO Model: Impact of External Carotid Artery Transection.

Authors:  Rebecca C Trueman; David J Harrison; Dominic M Dwyer; Stephen B Dunnett; Mathias Hoehn; Tracy D Farr
Journal:  Transl Stroke Res       Date:  2011-08-16       Impact factor: 6.829

7.  Stem cell mediation of functional recovery after stroke in the rat.

Authors:  Pedro Ramos-Cabrer; Carles Justicia; Dirk Wiedermann; Mathias Hoehn
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

8.  Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo.

Authors:  Romina A Badin; Michael Modo; Mike Cheetham; David L Thomas; David G Gadian; David S Latchman; Mark F Lythgoe
Journal:  J Cereb Blood Flow Metab       Date:  2008-09-10       Impact factor: 6.200

9.  Neither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT(1A) agonist in rat models of ischaemic stroke.

Authors:  Maria Ashioti; John S Beech; Andrew S Lowe; Michel Bernanos; Andrew McCreary; Michel M Modo; Steve C R Williams
Journal:  BMC Neurosci       Date:  2009-07-16       Impact factor: 3.288

10.  Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.

Authors:  Anthony C Vernon; Saga M Johansson; Michel M Modo
Journal:  BMC Neurosci       Date:  2010-01-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.